A collection of industry news reported on June 6th, including Akeso's success reported by China Daily, the general trend of Chinese companies outpacing Western counterparts, and the ASCO meeting held in Chicago.
6 reports, 3 independent
Updated Jul 3
Gone quiet
- Reports
- 6
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A collection of industry news reported on June 6th, including Akeso's success reported by China Daily, the general trend of Chinese companies outpacing Western counterparts, and the ASCO meeting held in Chicago.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Akeso, a Zhongshan-based company in Guangdong, reported that its drug outperformed MSD's Keytruda in trials, showcasing the rise of Chinese biotech.Sub-event
Akeso's drug outperformed competitor in Phase III trials while benefiting from Guangdong's biopharma ecosystem.1 source
Reports detail Akeso's success, the rise of Chinese companies, and the ASCO meeting in Chicago.1 source
Keep exploring
The entities involved
-
Akeso
Chinese Biopharmaceutical Company
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Eli Lilly and Company
American pharmaceutical company